共 29 条
[2]
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
[J].
LANCET INFECTIOUS DISEASES,
2016, 16 (06)
:661-673
[3]
Clinical and Laboratory Standards Institute, 2017, PERFORMANCE STANDARD
[4]
Compain F, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00451-17, 10.1128/aac.00451-17]
[6]
Donnenberg M.S., 2015, MAND DOUGLAS, P2503, DOI [DOI 10.1016/B978-1-4557-4801-3.00220-4, 10.1016/B978-1-4557-4801-3.00220-4]